Bing Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bing Xia has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Jiachen Li
Department of Biomedical Engineering, W.J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen/University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands
13 shared publicationsJisen Shi
11 shared publicationsDi Huang
Nanjing Forestry University
10 shared publicationsYan Gao
College of Science State Key Laboratory of Tree Genetics and Breeding Nanjing Forestry University Nanjing 210037 P. R. China
10 shared publications- Helder Almeida Santos
Department of Biomaterials and Biomedical Technology The Personalized Medicine Research Institute (PRECISION) University Medical Center Groningen University of Groningen Groningen The Netherlands
9 shared publications Zhenyu Chen
Key Laboratory of Forest Genetics & Biotechnology (Ministry of Education of China), College of Science, Nanjing Forestry University, Nanjing 210037, P. R. China
7 shared publications
Latest Publications
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
Biomimetic Nanozyme-Decoys Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition
Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
Biomimetic Nanozyme-Decoys Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition
Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.
- 4 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (82)
From Coordination Chemistry to Immune Modulation: Rational Design of Next‐Generation Mn 2+ ‐Based Immunomodulators
Mn 2+ has emerged as a potent immunostimulatory modulator capable of activating cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) and other innate immune signaling pathways. Consequently, Mn 2+ induces type I interferon responses, and promotes robust antitumor and antiviral immunity. Recent advances have revealed that Mn 2+ ‐protein coordination fundamentally shapes innate immune signaling and primes downstream adaptive immunity. Deciphering these molecular mechanisms is critical for understanding Mn 2+ –mediated immune modulation and for guiding the rational design and engineering of next‐generation Mn 2+ ‐based immunomodulators. In this perspective, we systematically examine the Mn 2+ coordination with diverse ligands, including inorganic anions, small molecules, polymers, and proteins, and their roles in regulating immune signaling, therapeutic efficacy, and nanosystem engineering. We further discuss design principles for data‐driven engineering Mn 2+ ‐based immunomodulators with precise spatiotemporal control over biodistribution and bioavailability, selective activation of immune signaling pathways, and improved therapeutic efficacy, biosafety, and clinical translatability. Overall, this perspective establishes a fundamental concept of “coordination‐mediated immune modulation”, advancing the emerging fields of metalloimmunology and metalloimmunotherapy.
- 4 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (82)
From Coordination Chemistry to Immune Modulation: Rational Design of Next‐Generation Mn 2+ ‐Based Immunomodulators
Mn 2+ has emerged as a potent immunostimulatory modulator capable of activating cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) and other innate immune signaling pathways. Consequently, Mn 2+ induces type I interferon responses, and promotes robust antitumor and antiviral immunity. Recent advances have revealed that Mn 2+ ‐protein coordination fundamentally shapes innate immune signaling and primes downstream adaptive immunity. Deciphering these molecular mechanisms is critical for understanding Mn 2+ –mediated immune modulation and for guiding the rational design and engineering of next‐generation Mn 2+ ‐based immunomodulators. In this perspective, we systematically examine the Mn 2+ coordination with diverse ligands, including inorganic anions, small molecules, polymers, and proteins, and their roles in regulating immune signaling, therapeutic efficacy, and nanosystem engineering. We further discuss design principles for data‐driven engineering Mn 2+ ‐based immunomodulators with precise spatiotemporal control over biodistribution and bioavailability, selective activation of immune signaling pathways, and improved therapeutic efficacy, biosafety, and clinical translatability. Overall, this perspective establishes a fundamental concept of “coordination‐mediated immune modulation”, advancing the emerging fields of metalloimmunology and metalloimmunotherapy.
- 12 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (7) , 5623-5633
AIE Fluorescent Nanozyme-Enabled Ratiometric Sensing Platform for Selective Detection of Ascorbic Acid and Alkaline Phosphatase
Ascorbic acid (AA) and alkaline phosphatase (ALP) are essential biomolecules involved in numerous physiological and pathological processes. However, conventional nanozyme assays based on AA reduction or ALP-mediated AA generation often suffer from interference from coexisting reductants, compromising their selectivity and analytical reliability. Here, we reported a rationally designed fluorescent nanozyme, ZIF-8/Ru@TPE, constructed by anchoring ultrasmall Ru nanoparticles onto ZIF-8 and assembling them with the aggregation-induced emission (AIE) luminogen tetraphenylethylene (TPE). The resulting hybrid exhibited strong intrinsic fluorescence at 445 nm and remarkable peroxidase-like activity. Upon the addition of H2O2 and o-phenylenediamine (OPD), ZIF-8/Ru@TPE catalyzed OPD oxidation to form the fluorescent product 2,3-diaminophenazine (DAP), yielding a distinct emission peak at 570 nm while quenching the TPE fluorescence at 445 nm. Notably, AA triggered a self-amplified ratiometric response by simultaneously inhibiting OPD oxidation and generating an additional fluorophore through the reaction of dehydroascorbic acid with OPD, achieving high selectivity over other reductants. Exploiting ALP-catalyzed AA production, this platform was successfully extended to ALP activity determination in serum. This study presents a versatile nanozyme-based ratiometric sensing strategy for selective detection of AA and ALP, offering great potential for accurate bioanalysis in complex samples.
- 12 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (7) , 5623-5633
AIE Fluorescent Nanozyme-Enabled Ratiometric Sensing Platform for Selective Detection of Ascorbic Acid and Alkaline Phosphatase
Ascorbic acid (AA) and alkaline phosphatase (ALP) are essential biomolecules involved in numerous physiological and pathological processes. However, conventional nanozyme assays based on AA reduction or ALP-mediated AA generation often suffer from interference from coexisting reductants, compromising their selectivity and analytical reliability. Here, we reported a rationally designed fluorescent nanozyme, ZIF-8/Ru@TPE, constructed by anchoring ultrasmall Ru nanoparticles onto ZIF-8 and assembling them with the aggregation-induced emission (AIE) luminogen tetraphenylethylene (TPE). The resulting hybrid exhibited strong intrinsic fluorescence at 445 nm and remarkable peroxidase-like activity. Upon the addition of H2O2 and o-phenylenediamine (OPD), ZIF-8/Ru@TPE catalyzed OPD oxidation to form the fluorescent product 2,3-diaminophenazine (DAP), yielding a distinct emission peak at 570 nm while quenching the TPE fluorescence at 445 nm. Notably, AA triggered a self-amplified ratiometric response by simultaneously inhibiting OPD oxidation and generating an additional fluorophore through the reaction of dehydroascorbic acid with OPD, achieving high selectivity over other reductants. Exploiting ALP-catalyzed AA production, this platform was successfully extended to ALP activity determination in serum. This study presents a versatile nanozyme-based ratiometric sensing strategy for selective detection of AA and ALP, offering great potential for accurate bioanalysis in complex samples.
- Open Access
- 3 August 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (5)
Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
Proinflammatory repolarization of tumor‐associated macrophages (TAMs) positively correlates with improved therapeutic outcomes in non‐small cell lung cancer (NSCLC), positioning TAM‐targeted immunotherapy as a promising strategy. Here, porous silicon nanoparticles (PSiNPs) are reported that enhance macrophage internalization of manganese@albumin nanocomplexes (M‐BSA), driving an endocytic shift from phagocytosis to clathrin‐mediated endocytosis. This endocytic programming facilitates the trafficking and endosomal aggregation of membrane‐anchored toll‐like receptor 4 (TLR4), redirecting downstream signaling toward the toll/interleukin‐1 receptor domain‐containing adaptor‐inducing interferon‐β (TRIF)‐biased pathway to trigger robust proinflammatory responses. Compared to free M‐BSA, M‐BSA@PSiNPs significantly elevate macrophage secretion of tumor necrosis factor‐α (TNF‐α), enhancing cytotoxicity against NSCLC cells in vitro. Combined with immune checkpoint blockade therapy, M‐BSA@PSiNPs synergistically repolarize TAM and remodel the immunosuppressive tumor microenvironment, resulting in potent eradication of established NSCLC tumors in vivo. These findings highlight the potential of M‐BSA@PSiNPs as a TLR4 nanoagonist platform for TAM‐mediated immunotherapy against NSCLC.
- 3 August 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (5)
Open AccessEndocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
Proinflammatory repolarization of tumor‐associated macrophages (TAMs) positively correlates with improved therapeutic outcomes in non‐small cell lung cancer (NSCLC), positioning TAM‐targeted immunotherapy as a promising strategy. Here, porous silicon nanoparticles (PSiNPs) are reported that enhance macrophage internalization of manganese@albumin nanocomplexes (M‐BSA), driving an endocytic shift from phagocytosis to clathrin‐mediated endocytosis. This endocytic programming facilitates the trafficking and endosomal aggregation of membrane‐anchored toll‐like receptor 4 (TLR4), redirecting downstream signaling toward the toll/interleukin‐1 receptor domain‐containing adaptor‐inducing interferon‐β (TRIF)‐biased pathway to trigger robust proinflammatory responses. Compared to free M‐BSA, M‐BSA@PSiNPs significantly elevate macrophage secretion of tumor necrosis factor‐α (TNF‐α), enhancing cytotoxicity against NSCLC cells in vitro. Combined with immune checkpoint blockade therapy, M‐BSA@PSiNPs synergistically repolarize TAM and remodel the immunosuppressive tumor microenvironment, resulting in potent eradication of established NSCLC tumors in vivo. These findings highlight the potential of M‐BSA@PSiNPs as a TLR4 nanoagonist platform for TAM‐mediated immunotherapy against NSCLC.
- 17 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112695
Rational design of ROS generation nanosystems to regulate innate immunity of macrophages, dendrtical and natural killing cells for immunotherapy
- 17 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112695
Rational design of ROS generation nanosystems to regulate innate immunity of macrophages, dendrtical and natural killing cells for immunotherapy
- 17 April 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (11) , 2865-2884
Cell-membrane engineering strategies for clinic-guided design of nanomedicine
In this review, four types of cell membrane functionalities and applications are summarized, which elucidate their working principles, outline the current approaches for engineering cell membranes, and discuss their potential clinical applications.
- 17 April 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (11) , 2865-2884
Cell-membrane engineering strategies for clinic-guided design of nanomedicine
In this review, four types of cell membrane functionalities and applications are summarized, which elucidate their working principles, outline the current approaches for engineering cell membranes, and discuss their potential clinical applications.
- Open Access
- 24 January 2024
- Published by Elsevier in Biomedical Journal
- Vol. 47 (4) , 100699
Multifunctional nanozymes for disease diagnosis and therapy
- 24 January 2024
- Published by Elsevier in Biomedical Journal
- Vol. 47 (4) , 100699
Open AccessMultifunctional nanozymes for disease diagnosis and therapy
- Open Access
- 5 December 2023
- Published by Wiley in Advanced Materials
- Vol. 36 (5) , e2310979
Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
The immunomodulatory effect of divalent manganese cations (Mn2+), such as activation of the cGAS−STING pathway or NLRP3 inflammasomes, positions them as adjuvants for cancer immunotherapy. In this study, it is found that trace Mn2+ ions, bound to bovine serum albumin (BSA) to form Mn@BSA nanocomplexes, stimulate pro‐inflammatory responses in human‐ or murine‐derived macrophages through TLR4‐mediated signaling cascades. Building on this, the assembly of Mn@BSA nanocomplexes to obtain nanowire structures enables stronger and longer‐lasting immunostimulation of macrophages by regulating phagocytosis. Furthermore, Mn@BSA nanocomplexes and their nanowires efficiently activate peritoneal macrophages, reprogramme tumor‐associated macrophages, and inhibit the growth of melanoma tumors in vivo. They also show better biosafety for potential clinical applications compared to typical TLR4 agonists such as lipopolysaccharides. Accordingly, the findings provide insights into the mechanism of metalloalbumin complexes as potential TLR agonists that activate macrophage polarization and highlight the importance of their nanostructures in regulating macrophage‐mediated innate immunity.
- 5 December 2023
- Published by Wiley in Advanced Materials
- Vol. 36 (5) , e2310979
Open AccessManganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
The immunomodulatory effect of divalent manganese cations (Mn2+), such as activation of the cGAS−STING pathway or NLRP3 inflammasomes, positions them as adjuvants for cancer immunotherapy. In this study, it is found that trace Mn2+ ions, bound to bovine serum albumin (BSA) to form Mn@BSA nanocomplexes, stimulate pro‐inflammatory responses in human‐ or murine‐derived macrophages through TLR4‐mediated signaling cascades. Building on this, the assembly of Mn@BSA nanocomplexes to obtain nanowire structures enables stronger and longer‐lasting immunostimulation of macrophages by regulating phagocytosis. Furthermore, Mn@BSA nanocomplexes and their nanowires efficiently activate peritoneal macrophages, reprogramme tumor‐associated macrophages, and inhibit the growth of melanoma tumors in vivo. They also show better biosafety for potential clinical applications compared to typical TLR4 agonists such as lipopolysaccharides. Accordingly, the findings provide insights into the mechanism of metalloalbumin complexes as potential TLR agonists that activate macrophage polarization and highlight the importance of their nanostructures in regulating macrophage‐mediated innate immunity.
- Open Access
- 4 January 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (2) , 1036-1053
Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
The development of nanosystems with intrinsic immunomodulatory effects on macrophage polarization is important for the macrophage-targeted immunotherapy. Here, mitochondria-targeted bovine serum albumins (BSAs) via the conjugation of fluorescent, lipophilic, and cationic rhodamine 110 molecules can efficiently enhance the gene expression of the proinflammatory phenotype of macrophages and correspondingly inhibit the gene expression of their anti-inflammatory phenotype. On this basis, porous silicon nanocarriers can further boost the immunomodulation of these mitochondria-targeted BSAs in vitro or in vivo, accompanied by the secretion of proinflammatory mediators including tumor necrosis factor α, nitric oxide, and reactive oxygen species (ROS). Meanwhile, BSA coatings can also improve the biocompatibility of porous silicon nanoparticulate cores on macrophages. Finally, the mechanism investigations demonstrate that porous silicon nanocarriers can efficiently deliver mitochondria-targeted BSA into macrophages to generate mitochondrial ROS via the interference with mitochondrial respiratory chains, which can further trigger the downstream signaling transduction pathways for the proinflammatory transition. Considering the good biosafety and versatile loading capability, this developed porous silicon@BSA nanosystem with a strong proinflmmatory regulatory effect has important potential on the combinatorial chemoimmunotherapy against cancer or viral/bacterial-related infectious diseases.
- 4 January 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (2) , 1036-1053
Open AccessPorous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
The development of nanosystems with intrinsic immunomodulatory effects on macrophage polarization is important for the macrophage-targeted immunotherapy. Here, mitochondria-targeted bovine serum albumins (BSAs) via the conjugation of fluorescent, lipophilic, and cationic rhodamine 110 molecules can efficiently enhance the gene expression of the proinflammatory phenotype of macrophages and correspondingly inhibit the gene expression of their anti-inflammatory phenotype. On this basis, porous silicon nanocarriers can further boost the immunomodulation of these mitochondria-targeted BSAs in vitro or in vivo, accompanied by the secretion of proinflammatory mediators including tumor necrosis factor α, nitric oxide, and reactive oxygen species (ROS). Meanwhile, BSA coatings can also improve the biocompatibility of porous silicon nanoparticulate cores on macrophages. Finally, the mechanism investigations demonstrate that porous silicon nanocarriers can efficiently deliver mitochondria-targeted BSA into macrophages to generate mitochondrial ROS via the interference with mitochondrial respiratory chains, which can further trigger the downstream signaling transduction pathways for the proinflammatory transition. Considering the good biosafety and versatile loading capability, this developed porous silicon@BSA nanosystem with a strong proinflmmatory regulatory effect has important potential on the combinatorial chemoimmunotherapy against cancer or viral/bacterial-related infectious diseases.